Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The war on bacteria has become a national crisis and the government is responding by kick starting a new antibacterial era with incentive money. The market is still free with much needed safeguards in place.
Sure looks like good news to me.
OC49 - New Exploratory Alzheimer’s Drug ANAVEX 2-73: Clinical Cognitive Improvement observed in Mini Mental State Examination (MMSE) and other Cognitive Markers in a Phase 2a Study in mild-to- moderate Alzheimer’s Patients.
I would like too second that. This is a huge positive update, thank you very much.
Most importantly to me is as far as I can tell Leo has worked hard and has done nothing nefarious to enrich himself while managing this company. His management missteps which have been discussed extensively here has given way for well orchestrated bastards to prey on the low DD, weak hand investors. IMO There are hundreds of late comers selling at a loss out of fear who will stumble back on this stock in a couple months and say " Damn I wish I hadn't sold that one".
"We saw the details in P300 biomarker results released in July. We could expect those results mirrored for up-to 32 patients as topline data"
July22 PR: ANAVEX 2-73 showed in 83 percent (10/12) of patients positive cognitive effects during PART A of the study.
Possibly those 2 patients are now seeing positive cognative effects after further dosage?
Lesson learned.
Due to low interest rates, Billions in savings was flushed down the toilet. Undue fear placed in the market the "Hilary effect".
Looking for: B-OM enrollment update. Kevetrin phase 1 update including finished enrollment. Phase 3 ABSSSI start date. Prurisol ahead of schedule...topline data update. Plenty of arrows in the quiver to boost share price.
And not deja vu all over again...One of my favorites.
Exactly. Leo has many irons in the fire. Partnerhip would ensure capital for trials and lab studies. Partnership would give share price the big lift to uplisting.
Thank You for reply KarinCA. Yes I see Leo expects two trials to run $12mm ($6mm each). I'm guessing trials would run both 2016 and 2017 budget cycles.
Further data showing A-273 results of improved cognitive thinking will be the gold standard.
I would think that the large trial requirement for a B-ABSSSI phase3 would be costly and require a partnership to prove capital availability as part of trial design. A hint might of been when Leo mentioned the design may be global. All just a guess.
This stock is showing strength even after that hellacious gut punch.
According to the PR, Orphan drug application was applied for in October 2014. FDA would have already given an answer. It's either yes or no based on patient treatment population of 200,000 or less.
Yes, I believe the PR was not posted on yahoo until 4pm or shortly after. Looking for buyer interest tomorrow. We will see. Thanks a lot.
This is also posted on yahoo. Just another ambulance chaser hitching to the original complaint.
Not sure what time this was posted on yahoo, never saw it this morning.
Christopher U. Missling, PhD, President and Chief Executive Officer, will present at the Ladenburg Thalmann 2015 Healthcare Conference on Tuesday, September 29, 4:00pm.
It says Missling will "present".. Possible Data update soon??
http://finance.yahoo.com/news/anavex-present-2015-ladenburg-thalmann-110000609.html
I'm loaded and holding .40-.80. Next data release could be epic. Good luck.
Clearly a buy and hold. A lot building behind the scenes. imo
Trial is about done and now waiting for great top line data release. Dr Missling gave early human trial details in his July22 PR. Trial study protocol is outlined and tracked on clinicaltrials.gov. Hoping for the best for Anavex. Good luck.
The idea is to attract new share holders.
Next run coming or not. "ANAVEX 2-73 Showing Early Evidence of Improving Cognition in Patients With Alzheimer’s Disease at AAIC 2015"
By the way the price spiked up the attendees must have been so impressed by the Brilacidin poster they got up and ran to call their brokers to lock in shares.
Another troll looking for a plaintiff. Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Cellceutix Corporation to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit
They are all in cahoots. Seems this last announcment has had no effect on disparaging sp. Maybe they have cried wolf too many times..
Another bs shareholder alert out. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellceutix Corporation – CTIX.
We are under attack plain and simple.
Awsome news today. MTA will lead to a licensing agreement. Bears will soon go back to their dens.
It doesn't matter if it's 1, 2 or 5. The perception being ctix is a scam and being well played. Leo needs to give us a patient enrollment update on all trials.
These baseless lawsuits on small pink sheet stocks have become a cost of doing business. IMO Stock will be sold down for a time while a faceless group accumulates then the suit fades away for higher highs.
Kevetrin radiation combo study using xenograft mouse models.
https://docs.google.com/file/d/0BzCMnkQtKcypMjBlNmRiYjctNmZmMS00ZjZkLTkwZGUtOTI1OGRiYjEwMTRh/edit?hl=en&pli=1
Prurisol is are upcoming ace in the hole. Doji reversal.
Prurisol trial expected to end this year which is much earlier then trial design. Hoping Leo will sell prurisol for big bucks early next year.
I fear this last minute class action lawsuit nonsense is going to screw us next week. I sure hope not.
Exactly my thought. The law firm is filing based strickly off a scandlous research piece and sour grape plaintiffs.
The law firm states that they are filing on behalf of purchasers. Evidently they got someone to bite on their earlier unfounded solicitation.
Hard as they may try there will be no reverse split.